SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

BioXcel Therapeutics Q1 EPS $(1.08) Misses $(0.94) Estimate

BioXcel Therapeutics (NASDAQ:BTAI) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0.94) by 14.89 percent. This is a 36.71 percent decrease over losses of $(0.79) per share

05/10/2021 07:16
BioXcel Therapeutics (NASDAQ:BTAI) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0.94) by 14.89 percent. This is a 36.71 percent decrease over losses of $(0.79) per share from the same period last year.